SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics
INGN 6.670-0.1%12:04 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (787)7/11/2008 1:30:31 PM
From: JibacoaRead Replies (1) of 802
 
Well, the CC with the Q&A, was longer than I thought, but in general it turned out better than I had expected.However, the general market isn't helping with the price of oil approaching $150 & gold in the way to $1000 <g>

I think I have now a better impression on Advexin, although still like INGN 241 a little more.<g>

If Advexin gets approved it seems it will be used by the Oncologists on other p53 positive tumors besides head and neck Cas.

Any one had the time to listen to the CC or has any opinion on it ?

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext